| abstract |
General formula: (Wherein, R 20 is —OCH 2 COOH or the like, R 21 is —CONH 2 or the like, R 22 is C4-C6 alkyl, R 23 is —CH 2 —R 18 (R 18 is aryl or the like), and R 24 is hydrogen atom or a C1-C6 alkyl), a compound represented by such as an optically active form thereof, that the prodrug or pharmaceutically acceptable salts thereof, or their solvate has an X-type sPLA 2 inhibition I found it. |